Blend Labs, Inc. Class A BLND 深 沪
已收盘 04-02 16:00:00 美东时间
2.00
+0.100
+5.26%
华盛通- 最 高2.0081
- 今 开1.85
- 成交量 349.63万股
- 最 低 1.84
- 昨 收 1.90
- 总市值 5.14亿
- 52周最高 4.49
- 市盈率 静 --
- 换手率 1.36%
- 52周最低 1.44
- 委 比 57.58%
- 总股本 2.57亿
- 历史最高 21.04
- 量 比 0.62
- 振 幅 8.85%
- 历史最低 0.5286
- 每 手 1
- 风险率 0.68%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Shares of companies within the broader technology sector are trading higher amid optimism that the Middle East conflict will conclude soon, which may ease inflation and rate-hike fears.
Shares of companies within the broader technology sector are trading higher ami...
04-02 03:50
美股大行评级 | 甲骨文绩后分歧大！小摩上调评级至"超配"，目标价缺降至210美元；科尔士百货、AVAV、Blend Labs、Domo遭多家大行下调评级
今日重点评级关注：LUCID CAPITAL MARKETS：上调INmune Bio评级至"买入" 目标价从2美元升至9美元；Clear Street：维持MoonLake Immunotherapeutics Class A"买入"评级，目标价从45美元升至70美元
03-12 12:34
Citizens Maintains Market Outperform on Blend Labs, Lowers Price Target to $5
Citizens analyst Aaron Kimson maintains Blend Labs (NYSE:BLND) with a Market Outperform and lowers the price target from $7 to $5.
03-11 19:32
Blend Labs Q4 Earnings Summary & Key Takeaways
Blend Labs (NYSE:BLND) reported its Q4 earnings results on Tuesday, March 10, 2...
03-11 04:08
Blend Labs: Q4 Earnings Insights
Blend Labs (NYSE:BLND) reported its Q4 earnings results on Tuesday, March 10, 2...
03-11 04:02
Blend Labs Sees Q1 Sales $28.500M-$30.000M vs $31.482M Est
Blend Labs (NYSE:BLND) sees Q1 sales of $28.500 million-$30.000 million vs $31.482 million analyst estimate.
03-11 04:01
Blend Labs Q4 Sales $32.368M Beat $31.778M Estimate
Blend Labs (NYSE:BLND) reported quarterly sales of $32.368 million which beat the analyst consensus estimate of $31.778 million by 1.86 percent. This is a 936.77 percent increase over sales of $3.122 million the same
03-11 04:01
Earnings Scheduled For March 10, 2026
Companies Reporting Before The Bell • Ultralife (NASDAQ:ULBI) is likely to repo...
03-10 19:11
Shares of software companies are trading lower after Citrini Research flagged risks AI could pose to the global economy. The move comes alongside broader market weakness, adding pressure to the sector
Shares of software companies are trading lower after Citrini Research flagged r...
02-24 04:28
美股大行评级 | 花旗上调英伟达目标价从210美元升至220美元；DraftKings、DoubleVerify遭多家大行下调目标价
今日重点评级关注：Guggenheim：维持InflaRx"买入"评级，目标价从10美元升至22美元；巴克莱：维持Tandem糖尿病护理"超配"评级，目标价从51美元升至55美元
2025-11-11 10:49
